A detailed history of Eisler Capital Management Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Eisler Capital Management Ltd. holds 90,300 shares of LLY stock, worth $92.3 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
90,300
Previous 69,600 29.74%
Holding current value
$92.3 Million
Previous $54.3 Million 26.99%
% of portfolio
0.3%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$625.65 - $812.69 $2.25 Million - $2.92 Million
3,596 Added 39.6%
12,676 $9.67 Million
Q2 2025

Aug 12, 2025

BUY
$713.71 - $898.95 $868,585 - $1.09 Million
1,217 Added 15.48%
9,080 $7.08 Million
Q1 2025

May 14, 2025

SELL
$725.72 - $929.72 $7.08 Million - $9.06 Million
-9,749 Reduced 55.35%
7,863 $6.49 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $12.8 Million - $16.4 Million
17,612 New
17,612 $13.6 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Eisler Capital Management Ltd. Portfolio

Follow Eisler Capital Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital Management Ltd. with notifications on news.